VENLAFAXINE extended-release tablets, for oral use

Manufacturer: Zydus Lifesciences Limited
Effective date: 2023-09-28
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-05-31 20:53:40

Label at a glance#

ProductVenlafaxine

Active ingredientVENLAFAXINE HYDROCHLORIDE

Label structure1 sections

Label contents#

Full prescribing information#

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Venlafaxine extended-release tablets, 37.5 mg

NDC 70771-1649-3

30 Tablets

Rx only

Venlafaxine extended-release tablets, 75 mg

NDC 70771-1650-3

30 Tablets

Rx only

Venlafaxine extended-release tablets, 150 mg

NDC 70771-1651-3

30 Tablets

Rx only

Venlafaxine extended-release tablets, 225 mg

NDC 70771-1652-3

30 Tablets

Rx only

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
808744	venlafaxine HCl 150 MG 24HR Extended Release Oral Tablet	PSN	2
808748	venlafaxine HCl 225 MG 24HR Extended Release Oral Tablet	PSN	2
808751	venlafaxine HCl 37.5 MG 24HR Extended Release Oral Tablet	PSN	2
808753	venlafaxine HCl 75 MG 24HR Extended Release Oral Tablet	PSN	2
808744	24 HR venlafaxine 150 MG Extended Release Oral Tablet	SCD	2
808748	24 HR venlafaxine 225 MG Extended Release Oral Tablet	SCD	2
808751	24 HR venlafaxine 37.5 MG Extended Release Oral Tablet	SCD	2
808753	24 HR venlafaxine 75 MG Extended Release Oral Tablet	SCD	2
808744	venlafaxine 150 MG (as venlafaxine hydrochloride) 24 HR Extended Release Oral Tablet	SY	2
808744	venlafaxine 150 MG 24 HR Extended Release Oral Tablet	SY	2
808748	venlafaxine 225 MG (as venlafaxine hydrochloride) 24 HR Extended Release Oral Tablet	SY	2
808748	venlafaxine 225 MG 24 HR Extended Release Oral Tablet	SY	2
808751	venlafaxine 37.5 MG (as venlafaxine hydrochloride) 24 HR Extended Release Oral Tablet	SY	2
808751	venlafaxine 37.5 MG 24 HR Extended Release Oral Tablet	SY	2
808753	venlafaxine 75 MG (as venlafaxine hydrochloride) 24 HR Extended Release Oral Tablet	SY	2
808753	venlafaxine 75 MG 24 HR Extended Release Oral Tablet	SY	2

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
VENLAFAXINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
17db3736-056c-48b9-b0f4-00fccabb14e6	Product name	5	20251118
7be8b949-f2c0-bdd8-e89d-8af92c1b2ead	Product name	9	20250224
b1435b59-059c-404b-a587-53656bf80e17	Product name	1	20230314
6005cd75-f7b1-d6be-3cb5-4bd30d5c4617	Product name	3	20190314

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
70771-1649-1	Venlafaxine	100 in 1 BOTTLE	TABLET, EXTENDED RELEASE	100	2
70771-1649-3	Venlafaxine	30 in 1 BOTTLE	TABLET, EXTENDED RELEASE	30	2
70771-1649-9	Venlafaxine	90 in 1 BOTTLE	TABLET, EXTENDED RELEASE	90	2
70771-1650-1	Venlafaxine	100 in 1 BOTTLE	TABLET, EXTENDED RELEASE	100	2
70771-1650-3	Venlafaxine	30 in 1 BOTTLE	TABLET, EXTENDED RELEASE	30	2
70771-1650-9	Venlafaxine	90 in 1 BOTTLE	TABLET, EXTENDED RELEASE	90	2
70771-1651-1	Venlafaxine	100 in 1 BOTTLE	TABLET, EXTENDED RELEASE	100	2
70771-1651-3	Venlafaxine	30 in 1 BOTTLE	TABLET, EXTENDED RELEASE	30	2
70771-1651-9	Venlafaxine	90 in 1 BOTTLE	TABLET, EXTENDED RELEASE	90	2
70771-1652-1	Venlafaxine	100 in 1 BOTTLE	TABLET, EXTENDED RELEASE	100	2
70771-1652-3	Venlafaxine	30 in 1 BOTTLE	TABLET, EXTENDED RELEASE	30	2
70771-1652-9	Venlafaxine	90 in 1 BOTTLE	TABLET, EXTENDED RELEASE	90	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70771-1649	VENLAFAXINE TABLET, EXTENDED RELEASE [ZYDUS LIFESCIENCES LIMITED]	2	Current NDC, Legacy NDC, 3 package rows	20231005_750333ce-a512-42e1-b9e3-179714b488df.zip
70771-1650	VENLAFAXINE TABLET, EXTENDED RELEASE [ZYDUS LIFESCIENCES LIMITED]	2	Current NDC, Legacy NDC, 3 package rows	20231005_750333ce-a512-42e1-b9e3-179714b488df.zip
70771-1651	VENLAFAXINE TABLET, EXTENDED RELEASE [ZYDUS LIFESCIENCES LIMITED]	2	Current NDC, Legacy NDC, 3 package rows	20231005_750333ce-a512-42e1-b9e3-179714b488df.zip
70771-1652	VENLAFAXINE TABLET, EXTENDED RELEASE [ZYDUS LIFESCIENCES LIMITED]	2	Current NDC, Legacy NDC, 3 package rows	20231005_750333ce-a512-42e1-b9e3-179714b488df.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

Venlafaxine
VENLAFAXINE HYDROCHLORIDE
CELLULOSE ACETATE
FERROSOFERRIC OXIDE
HYPROMELLOSE 2208 (100 MPA.S)
MAGNESIUM STEARATE
MANNITOL
MICROCRYSTALLINE CELLULOSE
POLYETHYLENE GLYCOL 400
POVIDONE K90
PROPYLENE GLYCOL
SHELLAC
SILICON DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
70771-1649	70771-1649-3, 70771-1649-9, 70771-1649-1
70771-1650	70771-1650-3, 70771-1650-9, 70771-1650-1
70771-1651	70771-1651-3, 70771-1651-9, 70771-1651-1
70771-1652	70771-1652-3, 70771-1652-9, 70771-1652-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 48 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
VENLAFAXINE HYDROCHLORIDE	7D7RX5A8MO	ACTIM
CELLULOSE ACETATE	3J2P07GVB6	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT
HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MANNITOL	3OWL53L36A	IACT
MICROCRYSTALLINE CELLULOSE	OP1R32D61U	IACT
POLYETHYLENE GLYCOL 400	B697894SGQ	IACT
POVIDONE K90	RDH86HJV5Z	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
SHELLAC	46N107B71O	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
VENLAFAXINE HYDROCHLORIDE	7D7RX5A8MO	ACTIM
CELLULOSE ACETATE	3J2P07GVB6	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT
HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MANNITOL	3OWL53L36A	IACT
MICROCRYSTALLINE CELLULOSE	OP1R32D61U	IACT
POLYETHYLENE GLYCOL 400	B697894SGQ	IACT
POVIDONE K90	RDH86HJV5Z	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
SHELLAC	46N107B71O	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
VENLAFAXINE HYDROCHLORIDE	7D7RX5A8MO	ACTIM
CELLULOSE ACETATE	3J2P07GVB6	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT
HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MANNITOL	3OWL53L36A	IACT
MICROCRYSTALLINE CELLULOSE	OP1R32D61U	IACT
POLYETHYLENE GLYCOL 400	B697894SGQ	IACT
POVIDONE K90	RDH86HJV5Z	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
SHELLAC	46N107B71O	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
VENLAFAXINE HYDROCHLORIDE	7D7RX5A8MO	ACTIM
CELLULOSE ACETATE	3J2P07GVB6	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT
HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	IACT

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A215622-001	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30
A215622-002	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30
A215622-003	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30
A215622-004	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A215622-001	AB
A215622-002	AB
A215622-003	AB
A215622-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 120 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A215622-001	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A215622-002	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A215622-003	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A215622-004	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A215622-001	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A215622-002	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A215622-003	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A215622-004	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A215622-001	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A215622-002	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A215622-003	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A215622-004	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A215622-001	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215622-002	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215622-003	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215622-004	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215622-001	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215622-002	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215622-003	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215622-004	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A215622-001	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215622-002	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215622-003	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215622-004	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215622-001	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215622-002	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215622-003	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215622-004	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215622-001	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215622-002	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215622-003	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215622-004	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215622-001	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215622-002	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215622-003	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215622-004	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215622-001	VENLAFAXINE HYDROCHLORIDE	EQ 37.5MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215622-002	VENLAFAXINE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215622-003	VENLAFAXINE HYDROCHLORIDE	EQ 150MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215622-004	VENLAFAXINE HYDROCHLORIDE	EQ 225MG BASE	TABLET, EXTENDED RELEASE / ORAL	AB	2022-08-30	`2680178bc6a6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 120 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-10-15 13:18:30	2026-09	A215622-001	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A215622-002	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A215622-003	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A215622-004	AB	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A215622-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A215622-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A215622-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A215622-004	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A215622-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A215622-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A215622-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A215622-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A215622-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215622-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215622-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215622-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215622-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215622-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215622-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215622-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A215622-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215622-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215622-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215622-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215622-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215622-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215622-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215622-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215622-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215622-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215622-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215622-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215622-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215622-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215622-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215622-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215622-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215622-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215622-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215622-004	AB	1	`2680178bc6a6…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Venlafaxine	VENLAFAXINE	Zydus Lifesciences Limited	750333ce-a512-42e1-b9e3-179714b488df	2023-09-28		Exact identifier ndc (package): 70771-1650-1 ndc (package): 70771-1650-3 ndc (package): 70771-1651-9 ndc (package): 70771-1651-3 ndc (package): 70771-1652-1 ndc (package): 70771-1652-3 ndc (package): 70771-1649-3 ndc (package): 70771-1649-9 ndc (package): 70771-1651-1 ndc (package): 70771-1649-1 ndc (package): 70771-1652-9 ndc (package): 70771-1650-9 ndc (product): 70771-1650 ndc (product): 70771-1652 ndc (product): 70771-1649 ndc (product): 70771-1651 ndc11 (package): 70771165101 ndc11 (package): 70771165001 ndc11 (package): 70771165003 ndc11 (package): 70771165103 ndc11 (package): 70771164901 ndc11 (package): 70771165009 ndc11 (package): 70771165203 ndc11 (package): 70771165209 ndc11 (package): 70771165201 ndc11 (package): 70771164909 ndc11 (package): 70771164903 ndc11 (package): 70771165109 spl id: 0bf02fa2-e5cd-42d6-ab41-1ecd150b7c57 spl set id: 750333ce-a512-42e1-b9e3-179714b488df

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.